Catheter Ablation versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF): study protocol for a randomised controlled trial

被引:0
作者
Habib Rehman Khan
Ines Kralj-Hans
Shouvik Haldar
Toufan Bahrami
Jonathan Clague
Anthony De Souza
Darrel Francis
Wajid Hussain
Julian Jarman
David Gareth Jones
Neeraj Mediratta
Raad Mohiaddin
Tushar Salukhe
Simon Jones
Joanne Lord
Caroline Murphy
Joanna Kelly
Vias Markides
Dhiraj Gupta
Tom Wong
机构
[1] Royal Brompton and Harefield NHS Trust,
[2] National Heart and Lung Institute,undefined
[3] Imperial College London,undefined
[4] Institute of Cardiovascular Medicine and Science,undefined
[5] Liverpool Heart and Chest Hospital NHS Trust,undefined
[6] New York University School of Medicine,undefined
[7] Southampton Health Technology Assessments Centre (SHTAC),undefined
[8] University of Southampton,undefined
[9] King’s Clinical Trials Unit,undefined
[10] Institute of Psychiatry,undefined
[11] King’s College London,undefined
[12] Royal Brompton Hospital,undefined
来源
Trials | / 19卷
关键词
Long-standing persistent atrial fibrillation; Catheter ablation; Thoracoscopic surgical ablation; Randomised clinical trial; Implantable loop recorder; Left atrial appendage exclusion;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 95 条
[1]  
Miyasaka Y(2006)Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 119-125
[2]  
Lim WY(2015)Management of atrial fibrillation: recommendations from NICE Br J Hosp Med (Lond) 76 C108-C112
[3]  
Khan F(2014)Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study Circulation 129 837-847
[4]  
Chugh SS(2012)2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation: developed with the special contribution of the European Heart Rhythm Association Europace 14 1385-1413
[5]  
Camm AJ(2017)The burden of proof: the current state of atrial fibrillation prevention and treatment trials Heart Rhythm 14 763-782
[6]  
Zakeri R(2000)The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy J Am Coll Cardiol 36 1303-1309
[7]  
Dorian P(1998)Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 946-952
[8]  
Benjamin EJ(2010)Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2369-2429
[9]  
Senoo K(2014)Updated NICE guideline: management of atrial fibrillation (2014) Expert Rev Cardiovasc Ther 12 1037-1040
[10]  
Lau YC(2004)Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK Heart 90 286-292